Medical sector’s Minerva Neurosciences’s (NASDAQ:NERV) Hold rating Reiterated by William Blair

0
56
stock_market_daily_information
Business or finance concept : Asia Pacific stock market data and candle stick graph chart on monitor

Minerva Neurosciences (NASDAQ:NERV)‘s stock had its Hold rating Reiterated by analysts at William Blair in a research report issued to clients and investors. A price-to-earnings ratio of #N/A, market cap of 139.6M and a beta of 1.58.  Minerva Neurosciences has a twelve month low $1.81 of  and a twelve month high of $15.22.

Shares of Minerva Neurosciences traded down -$0.21 on Thursday, reaching $3.56. 1819722 shares of the stock traded hands, compared to its average volume of 6323343. Shares of Minerva Neurosciences at end of the day on Thursday were at $3.56. The firm’s 50 day moving average is $$7.53 and its 200 day moving average is $6.82.Minerva Neurosciences  has a 12 month low of $3.48 and a 12 month high of $15.22. While on yearly highs and lows, Minerva Neurosciences’s today has traded high as $3.81 and has touched $3.48 on the downward trend. See More Analyst Rating at: RATING

Minerva Neurosciences (NASDAQ:NERV) Moving Average Technical Analysis

5 day Moving Average is $3.59 And 5 day price change is -$0.01 (-0.28%)  with average volume for 5 day average is 1,894,020. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $3.62 and 20 day price change is -$0.70 (-16.43%) and average 20 day moving volume is 2,733,680. 50 day moving average is $7.53  and 50 day price change is -$3.70 ( -50.96%)  and with average volume for 50 days is : 4,078,742. 200 day moving average is $6.82  and 200 day price change is -$4.55 (-56.10%)  and with average volume for 200 days is : 1,317,000.

See More Analyst Rating at: RATING

Minerva Neurosciences Earnings and What to expect: 

Minerva Neurosciences last announced its earnings results on May 4th, 2020. The biopharmaceutical company reported ($0.31) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.36) by $0.05. Minerva Neurosciences has generated ($1.85) earnings per share over the last year. Minerva Neurosciences has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, August 3rd, 2020 based off prior year’s report dates.

Latest Insiders Trading and Volume : 

  • Insider Ownership Percentage: 12.00%
  • On 12/17/2019 CAO Frederick W Ahlholm Sell 1,557 at average share price of $7.10 which equates to $11,054.70 in money value.
  • On 12/17/2019 CFO Geoff Race Sell 5,826 at average price of  $7.10 with total value of : Not Data Available
  • On 12/17/2019 COO Joseph H Reilly Sell 2,724 at average price of  $7.10 with total value of : $19,340.40

What other brokers have to say about Minerva Neurosciences :

  • 7/2/2020 – Seattle Genetics had its “buy” rating re-affirmed by analysts at William Blair. (View)
  • 6/30/2020 – Sitime is now covered by analysts at William Blair. They set an “outperform” rating on the stock. (View)
  • 6/29/2020 – Lattice Semiconductor had its “buy” rating re-affirmed by analysts at William Blair. (View)
  • 6/29/2020 – HD Supply had its “hold” rating re-affirmed by analysts at William Blair. (View)

Other firm’s rating by William Blair:

See More Analyst Rating at: RATING